Search results - ORA - Oxford University Research Archive

1

Conference item

Role of autophagy in immune aging

Richter, F, Friedrich, M, Alsaleh, G, et al.
2021-08-25

2

Conference item

Identification of thirty novel loci for cardiovascular magnetic resonance derived aortic distensibility in the UK Biobank

Fung, K, Biasiolli, L, Hann, E, et al.
2021-11-01

3

Conference item

Optimised misalignment correction from cine MR slices using statistical shape model

Banerjee, A, Zacur, E, Grau, V, et al.
2021-07-06

4

Conference item

Development and performance evaluation of a low-cost, high throughput, multiplex immunoassay of thirteen fever severity and etiology markers

Marlais, T, Handley, BL, Ashley, EA, et al.
2021-11-03

5

Conference item

Etiology of febrile neurological syndromes in low- and middle-income countries: results from the Fiebre study

Andelic, SA, Lal, S, Bramugy, J, et al.
2021-11-03

6

Conference item

Measuring pneumococcal conjugate vaccine impact in a low-resource setting with minimal baseline data

von Mollendorf, C, Lim, R, Choummanivong, M, et al.
2021-09-02

7

Conference item

Pneumococcal conjugate vaccine is effective against hypoxic pneumonia in Laos, Mongolia and Papua New Guinea

Nguyen, C, Weaver, R, Blyth, C, et al.
2021-09-02

8

Conference item

The main pathogens causing febrile illness and implications for fever management in Laos; results from the Fiebre study

Luangraj, M, Phimolnsarnnousith, V, Singhaxaiyaseng, S, et al.
2021-11-03

9

Conference item

Isovolumic relaxation time and e' metrics evaluated by deep-learning analysis of long-axis cine: correlations to atrial pressure and fibrosis

Peters, D, Lamy, J, Seemann, F, et al.
2021-04-30

10

Conference item

Concomitant use of statins in filgotinib-treated patients with rheumatoid arthritis

Taylor, PC, Charles-Schoeman, C, Alani, M, et al.
2021-05-19

11

Conference item

Automated tracking of the tricuspid valve plane in long-axis cine images with a 2-step deep learning pipeline

Gonzales, RA, Lamy, J, Seemann, F, et al.
2021-02-18

12

Conference item

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion

Ellayeh, MA, Bedawi, EO, Sundaralingam, A, et al.
2021-01-21

13

Conference item

Indwelling pleural catheter removal and auto-pleurodesis: predictors and outcome

Addala, DN, Bedawi, EO, Sundaralingam, A, et al.
2021-11-08

14

Conference item

Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion

Ellayeh, M, Bedawi, E, Banka, R, et al.
2021-11-25

15

Conference item

Study protocol for "Psilocybin as a treatment for anorexia nervosa: a pilot study"

Spriggs, MJ, Douglass, H, Park, RJ, et al.
2021-10-20

16

Conference item

Repressed chromatin drives leukaemogenesis in mutant IDH2 acute myeloid leukaemia via inhibition of granulocyte differentiation and cell cycle progression

Silveira, DRA, Chatzikyriakou, P, Yavorska, O, et al.
2021-11-23

17

Conference item

Outcomes for patients with late-stage mutant-IDH2 (m IDH2) relapsed/refractory acute myeloid leukemia (R/R AML) treated with enasidenib vs other lower-intensity therapies in the randomized, phase 3 IDHentify Trial

DiNardo, CD, Montesinos, P, Schuh, AC, et al.
2021-11-23

18

Conference item

Loss of COP9 signalosome gene-containing 2q region is associated with lenalidomide and pomalidomide resistance in myeloma patients

Gooding, S, Ansari-Pour, N, Kazeroun, MH, et al.
2021-11-23

19

Conference item

Health-related quality of life (HRQoL) during treatment with enasidenib (ENA) plus azacitidine (AZA) in patients with newly diagnosed mutant IDH2 (m IDH2) acute myeloid leukemia (AML) not eligible for intensive chemotherapy (IC)

DiNardo, CD, Dohner, H, Zeidan, AM, et al.
2021-11-23

20

Conference item

A phase 3, randomized, open-label study evaluating the safety and efficacy of magrolimab in combination with azacitidine in previously untreated patients with TP53-mutant acute myeloid leukemia

Daver, N, Vyas, P, Chao, M, et al.
2021-11-23

21

Conference item

A phase 2, open-label, multiarm, multicenter study to evaluate magrolimab combined with antileukemia therapies for first-line, relapsed/refractory, or maintenance treatment of acute myeloid leukemia

Vyas, P, Daver, N, Chao, M, et al.
2021-11-23

22

Conference item

Long-term prognosis after acute ST-segment elevation myocardial infarction is determined by characteristics in both non-infarcted and infarcted myocardium on cardiovascular magnetic resonance imaging

Shanmuganathan, M, Masi, A, Burrage, MK, et al.
2021-11-01

23

Conference item

A human arterial transcriptomic signature predicts major adverse cardiac events and identifies novel, redox-related therapeutic targets within the vascular wall

Kotanidis, CP, Lockstone, H, Polkinghorne, M, et al.
2021-10-14

24

Conference item

The standard G6PD test (SD biosensor) shows good repeatability and reproducibility in a multi-laboratory comparison

Ley, B, Satyagraha, AW, Kibria, MG, et al.
2021-11-03

25

Conference item

Novel human infection with an unknown species of Dracunculus, Vietnam

Sapp, SG, Thach, P, Van Doorn, HR, et al.
2021-11-03

26

Conference item

TEDS-Net: enforcing diffeomorphisms in spatial transformers to guarantee topology preservation in segmentations

Wyburd, MK, Jenkinson, M, Dinsdale, NK, et al.
2021-09-21

27

Conference item

Patient attitudes towards remote memory clinic assessment

Blane, J, ClareO'Donoghue, M, Craig, E, et al.
2021-12-31

28

Conference item

Pseudotime dynamics in pancreatic ductal adenocarcinoma reveal different mechanisms of hindrance in immunity through bifurcation of regulatory and cytotoxic T-cell differentiation

Jainarayanan, AK, Anand, NM, Arbe-Barnes, EH, et al.
2021-12-10

29

Conference item

Protocol design and preliminary evaluation of the REAL-Health Triple Aim, an open-cohort CVD-care optimisation initiative

Rison, SCG, Dostal, I, Ahmed, Z, et al.
2021-10-14

30

Conference item

Does multimorbidity influence the outcomes of total hip replacement for osteoarthritis?

Ferguson, R, Prieto-Alhambra, D, Peat, G, et al.
2021-10-12

31

Conference item

Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma

Couillard, S, Melhorn, J, Singhania, A, et al.
2021-11-08

32

Conference item

To what extent does the prototype ORACLE scale predict treatment benefits? Predicted versus observed impact of anti-inflammatory treatments

Couillard, S, Do, WIH, Beasley, R, et al.
2021-11-08

33

Conference item

Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis

Oliver, ME, Poole, S, Borg, C, et al.
2021-11-08

34

Conference item

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma

Couillard, S, Shrimanker, R, Chaudhuri, R, et al.
2021-11-08

35

Conference item

Improved COVID-19 outcomes in a large non-invasive respiratory support cohort despite new variants

Porter, BML, Turnbull, CD, Evans, SB, et al.
2021-11-08

36

Conference item

Anticipatory governance in the technology sector: processes, critiques and principles for addressing grand challenges in computing

Widdicks, K, Knowles, B, Blair, G, et al.
2021-05-08

37

Conference item

Health partnership solidarity and adapting to challenges in AMCGP management of delayed presenting clubfoot project

Drury, G, Nunn, T, Lavy, C, et al.
2021-10-12

38

Conference item

Design analysis and circuit topology optimization for programmable magnetic neurostimulator

Memarian Sorkhabi, M, Gingell, F, Wendt, K, et al.
2021-12-09

39

Conference item

A phase 3 study of Enasidenib (ENA) versus conventional care regimens (CCR) in older patients with late-stage mutant-IDH2 (MIDH2) relapsed/refractory acute myeloid leukemia (R/R AML)

Papayannidis, C, DiNardo, C, Montesinos, P, et al.
2021-10-21

40

Conference item

Genome‐wide association study of varicose veins in 810,625 individuals identifies 45 genetic risk loci

Ahmed, WUR, Wiberg, A, Ng, M, et al.
2021-04-27

41

Conference item

Genome-wide association analysis In 401,583 individuals identifies novel therapeutic targets for haemorrhoids

Ahmed, WULR, Wiberg, A, Ng, M, et al.
2021-10-12

42

Conference item

Genome-wide association analysis and replication in 810,625 individuals identifies novel therapeutic targets for varicose veins

Ahmed, WULR, Wiberg, A, Ng, M, et al.
2021-10-12

43

Conference item

Evidence for the genetic influence of waist-hip ratio on risk of kidney stone disease

Lovegrove, C, Wiberg, A, Littlejohns, T, et al.
2021-07-08

44

Conference item

Biased calcium-sensing receptor signalling in the pathogenesis of kidney stone disease

Wiberg, A, Goldsworthy, M, Turney, BW, et al.
2021-06-01

45

Conference item

Magrolimab + azacitidine versus azacitidine + placebo in untreated higher risk (HR) myelodysplastic syndrome (MDS): the phase 3, randomized, ENHANCE study

Garcia-Manero, G, Daver, NG, Xu, J, et al.
2021-05-28

46

Conference item

Magrolimab + azacitidine versus azacitidine + placebo in untreated higher risk (HR) myelodysplastic syndromes (MDS): the Phase 3, randomized, ENHANCE Study

Garcia-Manero, G, Daver, N, Xu, J, et al.
2021-08-30

47

Conference item

Magrolimab + azacitidine versus azacitidine + placebo in untreated higher risk myelodysplastic syndrome: the Phase 3, randomized, ENHANCE Study

Garcia-Manero, G, Daver, N, Xu, J, et al.
2021-10-15

48

Conference item

The first-in-class anti-CD47 antibody magrolimab in combination with azacitidine is well tolerated and effective in AML patients: phase 1b results

Sallman, D, Asch, A, Kambhampati, S, et al.
2021-08-30

49

Conference item

A phase Ib/II study of ivosidenib with venetoclax plus /- azacitidine in IDH1-mutated myeloid malignancies

Lachowiez, CA, Borthakur, G, Loghavi, S, et al.
2021-05-20

50

Conference item

A data integration pipeline towards reliable monitoring of phytoplankton and early detection of harmful algal blooms

Guterres, B, Khalid, S, Pias, M, et al.
2022-04-01

51

Conference item

The physical and mental health of young people in detention: A global scoping review

Borschmann, R, Janca, E, Willoughby, M, et al.
2021-02-26

52

Conference item

A digital transcranial magnetic stimulator for generating arbitrary pulse-shapes and patterns

Memarian Sorkhabi, M, Wendt, K, O'Shea, J, et al.
2021-11-01

53

Conference item

Assessing the causal impact of adiposity variation on rates of hospital admission: Application of Mendelian randomization

Hazewinkel, A-D, Richmond, RC, Wade, KH, et al.
2021-09-10

54

Conference item

Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans

Dahal, P, Singh-Phulgenda, S, Maguire, BJ, et al.
2021-09-27

55

Conference item

Once daily low-dose aspirin reduces urinary thromboxane B2 effectively even at 12-24 hours from dosing in the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial

Aung, T, Buck, GAN, Parish, S, et al.
2017-08-29

56

Conference item

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

Rocca, B, Buck, G, Petrucci, G, et al.
2020-11-25

57

Conference item

Transcranial doppler screening programme in children and adolescents with sickle cell disease: experience in a district general hospital in the UK

Brunelli, N, Petrou, N, Mohamed, BP, et al.
2020-11-07

58

Conference item

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector

Sergijenko, A, Moiseenko, A, Pineault, K, et al.
2021-04-27

59

Conference item

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Sinadinos, A, Sergijenko, A, Meng, C, et al.
2021-04-27

60

Conference item

Multistate modelling to investigate the impact of recurrent malaria episodes on hospital admissions and mortality

Dini, S, Douglas, N, Poespoprodjo, JR, et al.
2021-09-02

61

Conference item

Single-cell measurements of two-dimensional binding affinity across cell contacts

Chouliara, M, Junghans, V, Dam, T, et al.
2021-10-12

62

Conference item

Improved prediction of fracture risk leveraging a genome-wide polygenic risk score

Lu, T, Forgetta, V, Keller-Baruch, J, et al.
2021-02-03

63

Conference item

Effectiveness of Motivational Interviewing for secondary stroke prevention

Krishnamurthi, R, Barker-Collo, S, Witt, E, et al.
2017-08-22

64

Conference item

Genetic susceptibility, elevated blood pressure and risk of atrial fibrillation

Nazarzadeh, M, Pinho-Gomes, A-C, Bidel, Z, et al.
2021-04-09

65

Conference item

Systematic review of the performance and clinical utility of point-of-care HIV-1 RNA tests for diagnosis and care

Agutu, CA, Ngetsa, CJ, Price, MA, et al.
2018-10-22

66

Conference item

A first in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study)

Al-Mossawi, MH, Worth, C, McDonald, J, et al.
2021-09-01

67

Conference item

Guselkumab provides sustained domain-specific and comprehensive efficacy as assessed using composite endpoints in patients with active psoriatic arthritis free

Coates, LC, Ritchlin, CT, Gossec, L, et al.
2021-05-19

68

Conference item

A hand exercises mHealth app for patients with rheumatoid arthritis: development, design and usability study in Turkey

Tonga, E, Srikesavan, C, Williamson, E, et al.
2020-06-02

69

Conference item

Guselkumab-treated patients with psoriatic arthritis achieved clinically meaningful improvements in general health outcomes measured with PROMIS-29 through 52 weeks: results from the phase 3 DISCOVER-1 trial

Orbai, AM, Coates, LC, Deodhar, A, et al.
2021-05-19

70

Conference item

Protecting mental health by identifying children and their needs when an adult is ill

Hanna, JR, Dalton, LJ, Rapa, E
2021-09-20

71

Conference item

Dying in the midst of a pandemic: a qualitative study of bereaved relatives’ experiences about their family members deaths

Hanna, JR, Rapa, E, Dalton, L, et al.
2021-09-20

72

Conference item

The epidemiology of atopic dermatitis in children and adults in the UK: a population-based cohort study using primary care data

Broderick, C, Alexander, H, Dennis, J, et al.
2021-04-19

73

Conference item

Ensemble of deep convolutional neural networks with Monte Carlo dropout sampling for automated image segmentation quality control and robust deep learning using small datasets

Hann, E, Gonzales, RA, Popescu, IA, et al.
2021-07-06

74

Conference item

TVnet: automated time-resolved tracking of the tricuspid valve plane in MRI long-axis cine images with a dual-stage deep learning pipeline

Gonzales, RA, Lamy, J, Seemann, F, et al.
2021-09-21

75

Conference item

Factors associated with HBsAg-positive status in primary care in England: data from the Oxford-Royal College of General Practitioners Research (RCGP) and Surveillance Centre (RSC) network

Villa, G, Austin, H, Smith, C, et al.
2020-09-28

76

Conference item

The effect of organizational arrangements on people with type 2 diabetes and foot ulcers in Scotland

Meza-Torres, B, Cunningham, S, Leese, G, et al.
2020-09-30

77

Conference item

Altered peri‐implantation endometrial Treg in recurrent pregnancy loss

Granne, I, Shen, M, Rodriguez Caro, H, et al.
2021-08-25

78

Conference item

The role of female partners on men’s motivations to have a vasectomy: Findings from a qualitative study in the southern United States

White, A
2020-10-10

79

Conference item

Does infra-renal aortic neck diameter influence the durability of aneurysm sealing and aortic-specific outcome in patients undergoing endovascular aneurysm repair: real-world data from The Gore Global Registry for Endovascular Aortic Treatment (GREAT)

Howard, D
2017-06-08

80

Conference item

Effect of filgotinib on pain in patients with rheumatoid arthritis: results from phase 3 clinical trials

Pope, J, Taylor, P, Kavanaugh, A, et al.
2021-07-01

81

Conference item

Baricitinib 4mg and 2mg once-daily reduced pain in both patients who were opioid users and non-users in active rheumatoid arthritis: a post-hoc analysis of phase 3 trials

Pope, J, Lee, Y, Curtis, J, et al.
2020-07-01

82

Conference item

Antibiotics use as a proxy for microbiome alteration and hip fracture risk: A population-based case-control study

Pascual-Dapena, APD, Prats-Uribe, APU, Prieto-Alhambra, D
2021-03-03

83

Conference item

Differential impact of adiposity on risk of atrial fibrillation in men and women in UK Biobank

Camm, CJF, Lacey, B, Casadei, B, et al.
2020-11-25

84

Conference item

Real world cost and health outcomes of patients presented with chest pain in England: which is the most cost-effective first-line test?

Tsiachristas, A, West, HW, Oikonomou, EK, et al.
2020-11-25

85

Conference item

Evaluating the cost-effectiveness of population health interventions alongside literature reviews: the case of comprehensive geriatric assessment

Tsiachristas, A, Gardner, M, Ellis, G, et al.
2017-10-17

86

Conference item

Role of gap junctions in vasodilation

Dora, KA
2016-06-21

87

Conference item

Human coronary micro-artery dysfunction is associated with structural and smooth muscle cell phenotypic alteration

Borysova, L, Ye, X, Smart, N, et al.
2019-04-01

88

Conference item

Nerve-mediated responses in isolated myogenic and non-myogenic arteries

Lemmey, HAL, Garland, CJ, Dora, KA
2019-04-01

89

Conference item

Effects of the COVID-19 pandemic on management and outcomes of gestational diabetes

Hirst, J, Patell, M, Owen, K, et al.
2021-06-06

90

Conference item

Acceptability of the first trimester anomaly scan amongst parents in the UK

Karim, JN, Craik, R, Davidson, LM, et al.
2021-06-06

91

Conference item

Mode of administration in rheumatoid arthritis treatments: an exploration of patient preference for an 'ideal treatment'

Taylor, PC, Alten, R, Jesus Gomez-Reino, J, et al.
2016-11-08

92

Conference item

"I am always in pain somewhere": Continuing unmet need in rheumatoid arthritis

Taylor, PC, Alten, R, Jesus Gomez-Reino, J, et al.
2016-11-08

93

Conference item

Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment

Coates, LC, Birt, J, Kronbergs, A, et al.
2021-04-26

94

Conference item

Secukinumab provides sustained improvements in clinical and imaging outcomes in patients with psoriatic arthritis and axial manifestations: results from the MAXIMISE trial

Baraliakos, X, Gossec, L, Pournara, E, et al.
2021-04-26

95

Conference item

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

Coates, LC, Garrood, T, Gullick, N, et al.
2021-04-26

96

Conference item

Impact of upadacitinib or adalimumab as initial therapy on the achievement of 48-week treatment goals in patients with rheumatoid arthritis and inadequate response to methotrexate: Post hoc analysis of a phase 3 study

Mysler, E, Tanaka, Y, Kavanaugh, A, et al.
2021-05-19

97

Conference item

Physician and patient attitudes towards treat-to-target, its implementation and stated treatment goals in patients with rheumatoid arthritis in a real-world setting across Europe

Fautrel, B, Caporali, R, Holdsworth, E, et al.
2021-05-19

98

Conference item

Filgotinib-treated rheumatoid arthritis patients with high baseline neutrophil-to-lymphocyte ratio show better clinical response rates and patient-reported outcomes

Taylor, P, Downie, B, Kim, S, et al.
2021-05-19

99

Conference item

Differences in treatment satisfaction, patient preferences, and treatment patterns between European, South American, and Japanese patients with suboptimally controlled rheumatoid arthritis: a subgroup analysis of the SENSE study

Taylor, P, Sidiropoulos, P, Ancuta, C, et al.
2021-05-19

100

Conference item

Large scale hybrid assembly reveals the plasmid landscape associated with Gram-negative bloodstream infections

Lipworth, SIW, Matlock, W, Chau, K, et al.
2021-07-12